Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences

Power Life Sciences Inc.500 enrolled

Overview

The percentages of participants in clinical studies haven't always been perfectly representative of a particular group. This research examines the variables that affect a patient's choice to enroll in, discontinue participation in, or resume participation in a clinical trial for cervical cancer. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future cervical cancer studies.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Cervical Cancer

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged ≥ 18 years old * Ability to understand and the willingness to sign a written informed consent document. * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study. Exclusion Criteria: * Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial * Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a cervical cancer clinical study.

Time frame: 3 months

Number of cervical cancer study participants who remain in clinical trial until completion.

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

415-900-4227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.